Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg‐positive chronic hepatitis B naïve patients-Reference-Cited by-同舟云学术

Peg‐interferon alpha add‐on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg‐positive chronic hepatitis B naïve patients

Published:2021-07-14 Issue:10 Volume:28 Page:1381-1391
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Li Jing¹,Qu Lihong²,Sun Xuehua³,Liu Yanhong⁴,Gong Qiming⁵,Yu Demin¹,Zhang Donghua¹,Jiang Jiehong¹,Chen Jia¹,Wei Dong¹,Han Yue¹,Gao Yueqiu³,Zhang Qin⁴,She Weimin⁶,Chen Liang⁷,Zhang Jiming⁸^ORCID,Zhang Xinxin¹⁹

Affiliation:

1. Department of Infectious Diseases Research Laboratory of Clinical Virology Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

2. Department of Infectious Diseases East Hospital Tongji University Shanghai China

3. Liver Disease Department Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China

4. Department of Infectious Diseases Tongren Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

5. Department of Infectious Diseases Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

6. Department of Gastroenterology and Hepatology Zhongshan Hospital Fudan University Shanghai China

7. Department of Hepatic Diseases Shanghai Public Health Clinical Center Shanghai China

8. Department of Infectious Diseases Huashan Hospital Fudan University Shanghai China

9. Sino‐French Research Centre for Life Sciences and Genomics Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13571

Reference42 articles.

1. Hepatitis B Virus Infection — Natural History and Clinical Consequences

2. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

3. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

4. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

5. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of tenofovir dipivoxil plus entecavir in patients with HBeAg positive chronic hepatitis B;Tropical Journal of Pharmaceutical Research;2024-09-06

2. Editorial: Trajectory of soluble programmed cell death protein‐1 and ligand‐1 in HBV‐infected individuals treated with pegylated interferon—Implications for stopping rules and the HBV cure programme. Authors' reply;Alimentary Pharmacology & Therapeutics;2024-07-17

3. Hepatitis B cure: Current situation and prospects;World Journal of Hepatology;2024-06-27

4. Clinical cure of hepatitis B: Delight and anticipation;World Chinese Journal of Digestology;2023-10-28

5. Effectiveness of Different Antiviral Treatments and Timing of the Treatment Initiation in Hepatitis B Virus (HBV)-Infected Newborn Mice after Failure of Blocking Mother-to-Offspring Transmission;J BIOL REG HOMEOS AG;2023